BioTrinity is attended by an ever-evolving international audience of c.850 delegates, comprising a mix of academic entrepreneurs, early stage and emerging life sciences R&D companies, funders & investors, big pharma teams, charities & research bodies, government, regulatory bodies, along with professional services and expert supporters to the industry. 

This year’s event will feature a diverse global audience, international market showcases, dedicated investor networking, and presentations from the most promising life sciences companies.

*One Nucleus members receive 10% off registration, please email [email protected] for the discount code